Novo CEO pressed by Senate to chop price ranges of being overweight, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the company would look at new talks with insurers with regards to the record rates of Wegovy and copyright if they pledge to maintain the medicines on their own formularies. https://kethek.com/